Razumab -- the role of biosimilars for the treatment of retinal diseases

enthalten in: Drugs of today | 2021

von Ferro Desideri, L. | Cutolo, C. | Traverso, C. | +1

Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview

enthalten in: Drugs of today | 2021

von Viola, P. | Testa, V. | Ferro Desideri, L. | +6

An update on conbercept to treat wet age-related macular degeneration

enthalten in: Drugs of today | 2020

von Ferro Desideri, L. | Traverso, C. | Nicolo, M.

An update on ripasudil for the treatment of glaucoma and ocular hypertension

enthalten in: Drugs of today | 2020

von Testa, V. | Ferro Desideri, L. | Della Giustina, P. | +2

Omidenepag isopropyl for the treatment of glaucoma and ocular hypertension

enthalten in: Drugs of today | 2019

von Ferrero Desideri, L. | Cutolo, C. | Barra, F. | +2